Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
May-2014 Volume 31 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2014 Volume 31 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment

  • Authors:
    • Kyung Hee Lee
    • Eun Young Choi
    • Sung Ae Koh
    • Min Kyoung Kim
    • Byung Ik Jang
    • Sang Woon Kim
    • Jae-Ryong Kim
  • View Affiliations / Copyright

    Affiliations: Department of Hematology-Oncology, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea, Department of Gastro-Enterology, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea, Department of Surgery, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea, Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea
  • Pages: 2123-2130
    |
    Published online on: March 12, 2014
       https://doi.org/10.3892/or.2014.3086
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The potential of hepatocyte growth factor (HGF) to regulate the expression of urokinase plasminogen activator (uPA) in a gastric cancer cell is not widely acknowledged. To identify the genes associated with the plasminogen activator proteolytic axis by HGF, we used cDNA microarray technology and selected genes upregulated or downregulated in two gastric cell lines (NUGC-3 and MKN-28). First, IL-1β RNA and protein were confirmed to be upregulated. Then, we investigated the effect of IL-1β induced by HGF on the uPA system, facilitating the migration and invasion of cancer cells in the metastatic process. The role for IL-1β in HGF-induced upregulation of uPA was determined by knockdown of IL-1β with IL-1β shRNA and a chromatin immune precipitation assay. The levels of IL-1β and uPA were upregulated in cells treated with HGF in a dose-dependent manner. HGF-induced upregulation of uPA was suppressed by IL-1β knockdown. HGF enhanced the binding activity of NF-κB to the uPA promoter in control cells, but not in the IL-1β shRNA cells. We confirmed the functional role of HGF inactivation of the uPA promoter by a reporter gene assay. Downregulation of IL-1β using IL-1β shRNA also decreased cell proliferation and in vitro cell invasion. IL-1β stimulated uPA expression through ERK and NF-κB in gastric cancer, which may therefore be promising targets for gastric cancer therapy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

View References

1 

Pisani P, Parkin DM, Bray F and Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:18–29. 1999. View Article : Google Scholar

2 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar

3 

Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 61:759–767. 1990. View Article : Google Scholar : PubMed/NCBI

4 

Kinzler KW and Vogelstein B: Life (and death) in a malignant tumour. Nature. 379:19–20. 1996. View Article : Google Scholar : PubMed/NCBI

5 

Romer J: Skin cancer and wound healing. Tissue-specific similarities in extracellular proteolysis. APMIS. 111(Suppl 107): 1–36. 2003.

6 

Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 21:1104–1117. 2001. View Article : Google Scholar

7 

Foekens JA, Peters HA, Look MP, et al: The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res. 60:636–643. 2000.PubMed/NCBI

8 

Giavazzi R and Taraboletti G: Preclinical development of metalloproteasis inhibitors in cancer therapy. Crit Rev Oncol Hematol. 37:53–60. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Lee KH, Choi EY, Hyun MS, et al: Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: a potential therapeutic target for human stomach cancer. Korean J Intern Med. 21:20–27. 2006. View Article : Google Scholar

10 

Falsig J, Porzgen P, Lund S, Schrattenholz A and Leist M: The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem. 96:893–907. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Gottschall PE and Yu X: Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 64:1513–1520. 1995. View Article : Google Scholar : PubMed/NCBI

12 

De Vita F, Orditura M, Auriemma A, Infusino S and Catalano G: Serum concentrations of proinflammatory cytokines in advanced non small cell lung cancer patients. J Exp Clin Cancer Res. 17:413–417. 1998.PubMed/NCBI

13 

Asada M, Yasuda H, Ebihara S, et al: Interleukin-1β gene polymorphisms associated with risk of lung cancer in Japanese. Lung Cancer. 54:261–263. 2006.

14 

Niiya K, Shinbo M, Ozawa T, Hayakawa Y and Sakuragawa N: Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb Haemost. 74:1511–1515. 1995.PubMed/NCBI

15 

Tran-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M and Sordat B: Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer. 74:846–852. 1996. View Article : Google Scholar : PubMed/NCBI

16 

Yang SH, Kim JS, Oh TJ, et al: Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol. 22:741–750. 2003.PubMed/NCBI

17 

Schug J and Overton GC: Technical Report CBIL-TR-1997-1001-v0. 0. Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania; 1997

18 

Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 3:489–501. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Sidenius N and Blasi F: The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 22:205–222. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ and Tytgat GN: Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 29:425–429. 1994. View Article : Google Scholar : PubMed/NCBI

21 

Basso D, Scrigner M, Toma A, et al: Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res. 26:207–210. 1996. View Article : Google Scholar

22 

El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Guan Z, Baier LD and Morrison AR: p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β. J Biol Chem. 272:8083–8089. 1997.PubMed/NCBI

24 

Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF and Yang CM: IL-1β induces urokinse-plasminogen activator expression and cell migration through PKCα, JNK1/2, and NF-κB in A549 cells. J Cell Physiol. 219:183–193. 2009.

25 

Lee D, Yang Y, Lee S, et al: Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63:4648–4655. 2003.PubMed/NCBI

26 

Estrella VC, Eder AM, Liu S, et al: Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway. Int J Oncol. 31:441–449. 2007.PubMed/NCBI

27 

Reuning U, Guerrini L, Nishiguchi T, et al: Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells. Eur J Biochem. 259:143–148. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Kamio N, Hashizume H, Nakao S, Matsushima K and Sugiya H: IL-1β stimulates urokinase-type plasminogen activator expression and secretion in human dental pulp cells. Biomed Res. 28:315–322. 2007.

29 

Jung YD, Fan F, McConkey DJ, et al: Role of P38 MAPK, AP-1, and NF-κB in interleukin-1β-induced IL-8 expression in human vascular smooth muscle cells. Cytokine. 18:206–213. 2002.

30 

Kitadai Y, Takahashi Y, Haruma K, et al: Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lee KH, Choi EY, Koh SA, Kim MK, Jang BI, Kim SW and Kim J: IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Oncol Rep 31: 2123-2130, 2014.
APA
Lee, K.H., Choi, E.Y., Koh, S.A., Kim, M.K., Jang, B.I., Kim, S.W., & Kim, J. (2014). IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Oncology Reports, 31, 2123-2130. https://doi.org/10.3892/or.2014.3086
MLA
Lee, K. H., Choi, E. Y., Koh, S. A., Kim, M. K., Jang, B. I., Kim, S. W., Kim, J."IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment". Oncology Reports 31.5 (2014): 2123-2130.
Chicago
Lee, K. H., Choi, E. Y., Koh, S. A., Kim, M. K., Jang, B. I., Kim, S. W., Kim, J."IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment". Oncology Reports 31, no. 5 (2014): 2123-2130. https://doi.org/10.3892/or.2014.3086
Copy and paste a formatted citation
x
Spandidos Publications style
Lee KH, Choi EY, Koh SA, Kim MK, Jang BI, Kim SW and Kim J: IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Oncol Rep 31: 2123-2130, 2014.
APA
Lee, K.H., Choi, E.Y., Koh, S.A., Kim, M.K., Jang, B.I., Kim, S.W., & Kim, J. (2014). IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment. Oncology Reports, 31, 2123-2130. https://doi.org/10.3892/or.2014.3086
MLA
Lee, K. H., Choi, E. Y., Koh, S. A., Kim, M. K., Jang, B. I., Kim, S. W., Kim, J."IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment". Oncology Reports 31.5 (2014): 2123-2130.
Chicago
Lee, K. H., Choi, E. Y., Koh, S. A., Kim, M. K., Jang, B. I., Kim, S. W., Kim, J."IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment". Oncology Reports 31, no. 5 (2014): 2123-2130. https://doi.org/10.3892/or.2014.3086
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team